www.BuyersGuideChem.com - the directory of chemicals and chemical suppliers. The search engine opens a large data base and offers new supply sources
Welcome About BGC Terms of Use MSDS Banner Adverts Statistics Impressum Sitemap
BGC > Product Search > Lopinavir | 192725-17-0
english deutsch español

Suppliers for

Lopinavir



Properties

CAS   192725-17-0 
Formula   C37H48N4O5 

Structure

22 Registered suppliers




More details are to be found here


More details are to be found here


More details are to be found here


More details are to be found here
Molecular Formula: C37H48N4O5
Molecular Weight: 628.80

More details are to be found here
Molecular Formula: C37H48N4O5
Molecular Weight: 628.80

More details are to be found here
Molecular Formula: C37H48N4O5
Molecular Weight: 628.80

More details are to be found here
Molecular Formula: C37H48N4O5
Molecular Weight: 628.80

More details are to be found here
Molecular Formula: C37H48N4O5
Molecular Weight: 628.80

More details are to be found here


More details are to be found here
Description :
An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS.
  • Molecular Weight :628.81
  • Boiling Point :924.2±65.0 °C at 760 mmHg
  • Melting Point :95-98°C
  • Purity :≥98%
Molecular Formula :
C37H48N4O5
Canonical SMILES :
CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O
InChI :
InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1
InChIKey :
KJHKTHWMRKYKJE-SUGCFTRWSA-N
Solubility :
In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution
Appearance :
White Solid
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
ABT 378; ABT-378; ABT378; Aluviran; Kaletra

More details are to be found here
Description :
An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS.
  • Molecular Weight :628.81
  • Boiling Point :924.2±65.0 °C at 760 mmHg
  • Melting Point :95-98°C
  • Purity :≥98%
Molecular Formula :
C37H48N4O5
Canonical SMILES :
CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O
InChI :
InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1
InChIKey :
KJHKTHWMRKYKJE-SUGCFTRWSA-N
Solubility :
In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution
Appearance :
White Solid
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
ABT 378; ABT-378; ABT378; Aluviran; Kaletra

More details are to be found here
Description :
An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS.
  • Molecular Weight :628.81
  • Boiling Point :924.2±65.0 °C at 760 mmHg
  • Melting Point :95-98°C
  • Purity :≥98%
Molecular Formula :
C37H48N4O5
Canonical SMILES :
CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O
InChI :
InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1
InChIKey :
KJHKTHWMRKYKJE-SUGCFTRWSA-N
Solubility :
In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution
Appearance :
White Solid
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
ABT 378; ABT-378; ABT378; Aluviran; Kaletra

More details are to be found here
Description :
An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS.
  • Molecular Weight :628.81
  • Boiling Point :924.2±65.0 °C at 760 mmHg
  • Melting Point :95-98°C
  • Purity :≥98%
Molecular Formula :
C37H48N4O5
Canonical SMILES :
CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O
InChI :
InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1
InChIKey :
KJHKTHWMRKYKJE-SUGCFTRWSA-N
Solubility :
In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution
Appearance :
White Solid
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
ABT 378; ABT-378; ABT378; Aluviran; Kaletra

More details are to be found here
Description :
An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS.
  • Molecular Weight :628.81
  • Boiling Point :924.2±65.0 °C at 760 mmHg
  • Melting Point :95-98°C
  • Purity :≥98%
Molecular Formula :
C37H48N4O5
Canonical SMILES :
CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O
InChI :
InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1
InChIKey :
KJHKTHWMRKYKJE-SUGCFTRWSA-N
Solubility :
In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution
Appearance :
White Solid
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
ABT 378; ABT-378; ABT378; Aluviran; Kaletra

More details are to be found here
Description :
An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS.
  • Molecular Weight :628.81
  • Boiling Point :924.2±65.0 °C at 760 mmHg
  • Melting Point :95-98°C
  • Purity :≥98%
Molecular Formula :
C37H48N4O5
Canonical SMILES :
CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O
InChI :
InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1
InChIKey :
KJHKTHWMRKYKJE-SUGCFTRWSA-N
Solubility :
In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution
Appearance :
White Solid
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
ABT 378; ABT-378; ABT378; Aluviran; Kaletra

More details are to be found here
Description :
An antiretroviral medication acts as a protease inhibitor. It is a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS.
  • Molecular Weight :628.81
  • Boiling Point :924.2±65.0 °C at 760 mmHg
  • Melting Point :95-98°C
  • Purity :≥98%
Molecular Formula :
C37H48N4O5
Canonical SMILES :
CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O
InChI :
InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1
InChIKey :
KJHKTHWMRKYKJE-SUGCFTRWSA-N
Solubility :
In Vitro: DMSO: 100 mg/mL (159.03 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 2.5 mg/mL (3.98 mM); Clear solution
Appearance :
White Solid
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
ABT 378; ABT-378; ABT378; Aluviran; Kaletra

More details are to be found here

Detailed information on the suppliers of Lopinavir

Properties:

... more properties and specification on Lopinavir
© Copyright 1996 to 2024 by Netvertise GmbH. All rights reserved